Receptor Ligand VEGF-C
Details for Australian Patent Application No. 2003201371 (hide)
International Classifications
Event Publications
3 April 2003 Complete Application Filed
8 May 2003 Corrigenda
Complete Applications Filed - Name Index under the name Ludwig Institute for Cancer Research, Application No. 2003201371, Under INID (71) add applicant Helsinki University Licensing Ltd. OY.
12 June 2003 Application Open to Public Inspection
Published as AU-B-2003201371
1 March 2007 Application Accepted
Published as AU-B-2003201371
14 June 2007 Opposition Lodged
Genentech, Inc. has lodged an opposition against Helsinki University Licensing Ltd. OY; Ludwig Institute for Cancer Research.
18 December 2008 Opposition Proceeding - Application Withdrawn
The opposition by Genentech, Inc. against Helsinki University Licensing Ltd. OY; Ludwig Institute for Cancer Research has been withdrawn.
18 December 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
Application withdrawn under section 141(1). Examination has been requested or report issued for this patent. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser